Access the full text.
Sign up today, get DeepDyve free for 14 days.
B. Houcher, Zahira Houcher, A. Touabti, S. Begag, D. Torun, Y. Eğin, N. Akar, F. Kadour (2010)
Association of methylenetetrahydrofolate reductase C677T and cystathionine β-synthase polymorphisms in cardiovascular disease in the algerian population.Genetic testing and molecular biomarkers, 14 6
I. Graham, Leslie Daly, H. Refsum, Killian Robinson, L. Brattström, P. Ueland, R. Palma-Reis, G. Boers, Richard Sheahan, Bo Israelsson, C. Uiterwaal, R. Meleady, Dorothy McMaster, Petra Verhoef, J. Witteman, P. Rubba, Hélène Bellet, Jan Wautrecht, Harold Valk, A. Luis, Francoise Parrot-Roulaud, Kok Tan, I. Higgins, Danielle Garcon, Maria Medrano, Mirande Candito, Alun Evans, Generoso Andria (1997)
Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.JAMA, 277 22
Sundstrom (2003)
homocysteine hypertension incidence and blood pressure tracking the StudyPlasma Heart Hypertension
T. Bienvenu, A. Ankri, B. Chadefaux, G. Montalescot, P. Kamoun (1993)
Elevated total plasma homocysteine, a risk factor for thrombosis. Relation to coagulation and fibrinolytic parameters.Thrombosis research, 70 2
G. Dogra, A. Irish, G. Watts (2001)
Homocysteine and nephrotic syndrome.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 16 8
Dogra (2001)
AB nephrotic syndrome Transplant, 16
M. Cuer, S. Barrot, F. Jauréguy, D. Manéné, G. Durand, G. Moël (1999)
The plasma homocysteine/creatinine ratio can be used to study the implication of (C677T) MTHFR genetic variants in homocysteine homeostasis.Clinical chemistry, 45 8 Pt 1
C. Falcon, M. Cattaneo, Daniela Panzeri, I. Martinelli, P. Mannucci (1994)
High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.Arteriosclerosis and thrombosis : a journal of vascular biology, 14 7
Ueland (1992)
homocysteine cardiovascular disease In editor Atherosclerotic cardiovascular disease hemostasis endothelial function New York MarcelPlasma
L. Brattström, A. Lindgren, B. Israelsson, A. Andersson, B. Hultberg (1994)
Homocysteine and cysteine: determinants of plasma levels in middle‐aged and elderly subjectsJournal of Internal Medicine, 236
A. Hak, K. Polderman, I. Westendorp, Cornelis Jakobs, A. Hofman, J. Witteman, Coen Stehouwer (2000)
Increased plasma homocysteine after menopause.Atherosclerosis, 149 1
I. Quéré, J. Gris, M. Dauzat (2005)
Homocysteine and venous thrombosis.Seminars in vascular medicine, 5 2
E. Tavares, J. Vieira-Filho, A. Andriolo, A. Perez, N. Vergani, A. Sañudo, S. Gimeno, L. Franco (2004)
Serum total homocysteine levels and the prevalence of folic acid deficiency and C677T mutation at the MTHFR gene in an indigenous population of Amazonia: the relationship of homocysteine with other cardiovascular risk factors.Ethnicity & disease, 14 1
D. Wald, M. Law, J. Morris (2002)
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysisBMJ : British Medical Journal, 325
J. Brezovska-Kavrakova, M. Krstevska, G. Bosilkova, S. Alabakovska, S. Panov, N. Orovchanec (2013)
Hyperhomocysteinemia and of Methylenetetrahydrofolate Reductase (C677T) Genetic Polymorphism in Patients with Deep Vein ThrombosisMateria Socio-Medica, 25
M. Silverstein, J. Heit, D. Mohr, T. Petterson, W. O'fallon, L. Melton (1998)
Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study.Archives of internal medicine, 158 6
McCully (1969)
pathology of homocysteinemia : implications for the pathogenesis of arteriosclerosisVascular Am J Pathol, 28
Mansoor (1993)
Bergmark Swedenborg de Faire Hyperhomocysteinemia in patients operated for lower extremity ischemia below the age of Effect of smoking and extent of diseaseAM Eur J Vasc Surg
Tore Amundsen, P. Ueland, A. Waage (1995)
Plasma homocysteine levels in patients with deep venous thrombosis.Arteriosclerosis, thrombosis, and vascular biology, 15 9
D. Gemmati, M. Serino, S. Moratelli, R. Mari, G. Ballerini, G. Scapoli (1998)
Coexistence of antithrombin deficiency, factor V Leiden and hyperhomocysteinemia in a thrombotic family.Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 9 2
K. Mccully (1969)
Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis.The American journal of pathology, 56 1
Wald (2002)
cardiovascular disease : evidence on causality from a meta - analysisLaw Med
N. Dionisio, I. Jardin, G. Salido, J. Rosado (2010)
Homocysteine, intracellular signaling and thrombotic disorders.Current medicinal chemistry, 17 27
P. Jacques, A. Bostom, P. Wilson, S. Rich, I. Rosenberg, J. Selhub (2001)
Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort.The American journal of clinical nutrition, 73 3
Casais (2009)
Pilot study of homocysteine and cysteine in patients with thrombosis in different vascular sites and response to folateEpidemiology Thromb Res
Y. Ünlü, S. Keleş, N. Becit, C. Koçoğulları, H. Koçak, Ebubekir Bakan (2005)
Hyperhomocysteinaemia as a risk factor for deep-vein thrombosis.European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 30 3
Hyun Kim, M. Kim, J. Kim, H. Ha, B. Choi (2010)
Major Determinants of Serum Homocysteine Concentrations in a Korean PopulationJournal of Korean Medical Science, 25
P. Ueland, H. Refsum (2000)
Plasma Homocysteine and Cardiovascular Disease
P. Durand, S. Lussier‐Cacan, D. Blache (1997)
Acute methionine load‐induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage‐derived tissue factor activity in ratsThe FASEB Journal, 11
M. Heijer, T. Koster, Henk Blom, G. Bos, E. Briët, P. Reitsma, J. Vandenbroucke, F. Rosendaal (1996)
Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.The New England journal of medicine, 334 12
M. Donner, G. Klein, Peter Mathes, P. Schwandt, W. Richter (1998)
Plasma total homocysteine levels in patients with early-onset coronary heart disease and a low cardiovascular risk profile.Metabolism: clinical and experimental, 47 3
M. Heijer, S. Lewington, R. Clarke (2005)
Homocysteine, MTHFR and risk of venous thrombosis: a meta‐analysis of published epidemiological studiesJournal of Thrombosis and Haemostasis, 3
J. Sundström, L. Sullivan, R. D'Agostino, P. Jacques, J. Selhub, I. Rosenberg, P. Wilson, D. Levy, R. Vasan (2003)
Plasma Homocysteine, Hypertension Incidence, and Blood Pressure Tracking: The Framingham Heart StudyHypertension: Journal of The American Heart Association, 42
M. Heijer, W. Gerrits, H. Haak, P. Wijermans, G. Bos, H. Blom, F. Rosendaal (1995)
Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?The Lancet, 345
P. Simioni, P. Prandoni, A. Burlina, D. Tormene, C. Sardella, V. Ferrari, L. Benedetti, A. Girolami (1996)
Hyperhomocysteinemia and deep-vein thrombosis. A case-control study.Thrombosis and haemostasis, 76 6
J. Selhub, A. D’Angelo (1997)
Hyperhomocysteinemia and Thrombosis: Acquired ConditionsThrombosis and Haemostasis, 78
C. Bergmark, M. Mansoor, J. Swedenborg, U. Faire, A. Svardal, P. Ueland (1993)
Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50--effect of smoking and extent of disease.European journal of vascular surgery, 7 4
(2005)
Relationship between plasma homocysteine concentration and urinary markers of tubulointestinal injury
C. Boushey, S. Beresford, G. Omenn, A. Motulsky (1995)
A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.JAMA, 274 13
Bourouba (1691)
The prevalence of methylenetetrahydrofolate reductase factor prothrombin mutations in healthy populations inClin Appl, 15
L. Qiu, Sheng-kai Yan, Yao-hong Song (2003)
[Hyperhomocysteinemia and deep-vein thrombosis].Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 25 6
Marshall Stanton (1996)
Homocysteine and cardiovascular diseaseCardiology in Review, 4
A. Bostom, Lori Lathrop (1997)
Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes.Kidney international, 52 1
Refsum (1998)
cardiovascular diseaseAnnu Rev Med, 49
S. Edirisinghe (2004)
Homocysteine-induced thrombosisBritish Journal of Biomedical Science, 61
L. Brattström, L. Tengborn, C. Lagerstedt, B. Israelsson, B. Hultberg (1991)
Plasma homocysteine in venous thromboembolism.Haemostasis, 21 1
Earl Ford, S. Smith, D. Stroup, Karen Steinberg, Patricia Mueller, Stephen Thacker (2002)
Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies.International journal of epidemiology, 31 1
Huub WILLEMS1, Martin HEIJER2, Gerard BOS3 (2000)
Homocysteine and Venous Thrombosis: Outline of a Vitamin Intervention TrialSEMINARS IN THROMBOSIS AND HEMOSTASIS, Volume 26
N. Hanson, O. Aras, Feng Yang, M. Tsai (2001)
C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease.Clinical chemistry, 47 4
S. Mudd, F. Skovby, H. Levy, Pettigrew Kd, B. Wilcken, Pyeritz Re, G. Andria, G. Boers, Bromberg Il, R. Cerone (1985)
The natural history of homocystinuria due to cystathionine beta-synthase deficiency.American journal of human genetics, 37 1
Heijer (2005)
Den and risk of venous thrombosis : a meta - analysis of published epidemiological studies
Brattstrom (1994)
cysteine determinants of plasma levels in middle - aged and elderly subjectsJ Intern Med
Cattaneo (1996)
Hyperhomocysteinemia as a risk factor for deep - vein thrombosisEngl J Med
H. Ravari, Zafarghandi Mr, D. Alvandfar, S. Saadat (2009)
Serum homocysteine in deep venous thrombosis, peripheral atherosclerosis and healthy Iranians: a case-control study.Pakistan journal of biological sciences : PJBS, 12 14
R. Bourouba, B. Houcher, F. Djabi, Y. Eğin, N. Akar (2009)
The Prevalence of Methylenetetrahydrofolate Reductase 677 C-T, Factor V 1691 G-A, and Prothrombin 20210 G-A Mutations in Healthy Populations in Sétif, AlgeriaClinical and Applied Thrombosis/Hemostasis, 15
Lily Wu, James Wu, S. Hunt, B. James, G. Vincent, Roger Williams, P. Hopkins (1994)
Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease.Clinical chemistry, 40 4
O. Stanger, W. Herrmann, K. Pietrzik, Brian Fowler, J. Geisel, J. Dierkes, M. Weger (2004)
Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseasesZeitschrift für Kardiologie, 93
M. Mansoor, C. Bergmark, A. Svardal, P. Lønning, P. Ueland (1995)
Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Homocysteine and peripheral vascular disease.Arteriosclerosis, thrombosis, and vascular biology, 15 2
Ravari (2009)
Serum homocysteine in deep venous thrombosis peripheral healthy a case - control studyatherosclerosis Biol Sci, 12
P. Casais, M. Alberto, M. Salviú, S. Meschengieser, M. Aixalá, M. Lazzari (2009)
Pilot study of homocysteine and cysteine in patients with thrombosis in different vascular sites. Epidemiology and response to folate.Thrombosis research, 123 4
R. Francis (1992)
Atherosclerotic cardiovascular disease, hemostasis, and endothelial function
G. Kamat, S. Metgud, Vishwanath Pattanshetti, A. Godhi (2010)
A Cross-Sectional Study to Detect the Prevalence of Hyperhomocysteinemia in Cases of Deep Vein ThrombosisIndian Journal of Surgery, 72
S. Gartler, S. Hornung, A. Motulsky (1981)
Effect of chronologic age on induction of cystathionine synthase, uroporphyrinogen I synthase, and glucose-6-phosphate dehydrogenase activities in lymphocytes.Proceedings of the National Academy of Sciences of the United States of America, 78 3
L. Kluijtmans, M. Heijer, P. Reitsma, S. Heil, H. Blom, F. Rosendaal (1998)
Thermolabile Methylenetetrahydrofolate Reductase and Factor V Leiden in the Risk of Deep-Vein ThrombosisThrombosis and Haemostasis, 79
Abstract We studied total plasma homocysteine levels (tHcy) in Algerian patients with a deep venous thrombosis (DVT). We measured tHcy levels in a total of 99 subjects enrolled in this study, including 40 patients with DVT and 59 healthy controls. The mean tHcy level in the patients was 12.62±8.7 μmol/L and that in the controls was 10.2± 2.1 μmol/L. In a univariate regression model, tHcy concentrations were inversely correlated with triglycerides (TG) ( r =–0.358; p=0.023) and total cholesterol (TC) ( r =–0.454; p=0.003) concentrations. Logistic regression analysis showed that tHcy after adjustment was significantly associated with the following factors: TC (p=0.003) and TG (p=0.023). The analysis in DVT patients showed that variables independently associated with tHcy were TC (odds ratio (OR) 2.1, 95% confidence interval (CI) 1.7–2.6), low-density lipoprotein cholesterol (OR 2.0, 95% CI 1.6–2.5), creatinine (OR 2.2, 95% CI 1.7–2.6), and smoking (OR 2.1, 95% CI 1.7–2.5). In conclusion, these results indicate that tHcy levels and other biochemical parameters are important determinant factors for DVT diseases in Algerian patients.
Pteridines – de Gruyter
Published: Dec 1, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.